(Q44636663)

English

Highly purified CD38 sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38 sub-populations derived from the same chronic lymphocytic leukaemia patient

scientific article published on 22 May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Highly purified CD38 sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38 sub-populations derived from the same chronic lymphocytic leukaemia patient (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Thet Thet Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Saman Hewamana

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Rachel Ward

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hannah Taylor

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Tammy Payne

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Guy Pratt

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Chris Fegan

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Chris Pepper

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

22 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

142

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

595-605

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Extensive allelic variation and ultrashort telomeres in senescent human cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Intra-allelic mutation at human telomeres

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Signaling through CD38 induces NK cell activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Telomeres and chromosomal instability.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3-zeta immune receptor tyrosine-based activation motifs.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Activation-induced cytidine deaminase and CD38 expression in B-cell chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07236.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2008.07236.X

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44636663&oldid=2030440952"